Literature DB >> 16313222

Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation.

David Butler1, Queenie B Brown, Douglas J Chin, Lara Batey, Sanjida Karim, Manpreet S Mutneja, David A Karanian, Ben A Bahr.   

Abstract

Protein oligomerization and aggregation are key events in age-related neurodegenerative disorders, causing neuronal disturbances including microtubule destabilization, transport failure and loss of synaptic integrity that precede cell death. The abnormal buildup of proteins can overload digestive systems and this, in turn, activates lysosomes in different disease states and stimulates the inducible class of lysosomal protein degradation, macroautophagy. These responses were studied in a hippocampal slice model well known for amyloidogenic species, tau aggregates, and ubiquitinated proteins in response to chloroquine-mediated disruption of degradative processes. Chloroquine was found to cause a pronounced appearance of prelysosomal autophagic vacuoles in pyramidal neurons. The vacuoles and dense bodies were concentrated in the basal pole of neurons and in dystrophic neurites. In hippocampal slice cultures treated with Abeta(142), ultrastructural changes were also induced. Autophagic responses may be an attempt to compensate for protein accumulation, however, they were not sufficient to prevent axonopathy indicated by swellings, transport deficits, and reduced expression of synaptic components. Additional chloroquine effects included activation of cathepsin D and other lysosomal hydrolases. Abeta(142) produced similar lysosomal activation, and the effects of Abeta(142) and chloroquine were not additive, suggesting a common mechanism. Activated levels of cathepsin D were enhanced with the lysosomal modulator Z-Phe-Ala-diazomethylketone (PADK). PADK-mediated lysosomal enhancement corresponded with the restoration of synaptic markers, in association with stabilization of microtubules and transport capability. To show that PADK can modulate the lysosomal system in vivo, IP injections were administered over a 5-day period, resulting in a dose-dependent increase in lysosomal hydrolases. The findings indicate that degradative responses can be modulated to promote synaptic maintenance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313222     DOI: 10.1089/rej.2005.8.227

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  19 in total

1.  Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases.

Authors:  Ben A Bahr; Meagan L Wisniewski; David Butler
Journal:  Rejuvenation Res       Date:  2012-04       Impact factor: 4.663

Review 2.  Autophagy: molecular machinery, regulation, and implications for renal pathophysiology.

Authors:  Sudharsan Periyasamy-Thandavan; Man Jiang; Patricia Schoenlein; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11

Review 3.  Protein misfolding, aggregation, and autophagy after brain ischemia.

Authors:  Tianfei Luo; Yujung Park; Xin Sun; Chunli Liu; Bingren Hu
Journal:  Transl Stroke Res       Date:  2013-11-09       Impact factor: 6.829

4.  Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

Authors:  Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr
Journal:  Eur Sci J       Date:  2017-10

5.  Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro.

Authors:  Nan Mao; Yuan Cheng; Xin-li Shi; Li Wang; Ji Wen; Qiong Zhang; Qiong-dan Hu; Jun-ming Fan
Journal:  Acta Pharmacol Sin       Date:  2014-03-17       Impact factor: 6.150

6.  Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.

Authors:  Kishore Viswanathan; Dennis J Hoover; Jeannie Hwang; Meagan L Wisniewski; Uzoma S Ikonne; Ben A Bahr; Dennis L Wright
Journal:  ACS Med Chem Lett       Date:  2012-09-09       Impact factor: 4.345

Review 7.  Autophagy in dementias.

Authors:  Christine Lund Kragh; Kiren Ubhi; Tony Wyss-Coray; Tony Wyss-Corey; Eliezer Masliah
Journal:  Brain Pathol       Date:  2012-01       Impact factor: 6.508

8.  Gephyrin alterations due to protein accumulation stress are reduced by the lysosomal modulator Z-Phe-Ala-diazomethylketone.

Authors:  Sophia Ryzhikov; Ben A Bahr
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

9.  Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.

Authors:  Lonnie Schneider; Jianhua Zhang
Journal:  Mol Neurodegener       Date:  2010-04-13       Impact factor: 14.195

Review 10.  Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death.

Authors:  Violetta N Pivtoraiko; Sara L Stone; Kevin A Roth; John J Shacka
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.